Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Matches Lilly In Grant Spending For 1st Quarter; Fibromyalgia Is Focus

Executive Summary

Pfizer and Lilly dispensed comparable amounts in grants during the first quarter of 2008, as revealed by Pfizer's inaugural online posting of gifts and charitable donations, unveiled May 15

You may also be interested in...



Pfizer CME Restrictions: No Support For Education Firms, Caps Everywhere Else

In response to the medical community's call for continuing medical education to receive financing from a variety of sources, Pfizer is limiting the percentage of funding it will provide for any one CME program

Pfizer CME Restrictions: No Support For Education Firms, Caps Everywhere Else

In response to the medical community's call for continuing medical education to receive financing from a variety of sources, Pfizer is limiting the percentage of funding it will provide for any one CME program

Amgen CME Grants Equal 0.4% Of Sales – More Than Pfizer, Less Than Lilly

Educational grants and donations made by the Amgen Medical Education department totaled more than $11 million in the first quarter of 2008, according to an inaugural Web posting May 22

Related Content

UsernamePublicRestriction

Register

PS049649

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel